Guggenheim Forecasts Strong Price Appreciation for Cidara Therapeutics (NASDAQ:CDTX) Stock
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its target price upped by Guggenheim from $50.00 to $68.00 in a research report report published on Tuesday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. CDTX has been the subject of several other reports. Wall Street Zen raised shares of Cidara Therapeutics to […]
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its target price upped by Guggenheim from $50.00 to $68.00 in a research report report published on Tuesday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. CDTX has been the subject of several other reports. Wall Street Zen raised shares of Cidara Therapeutics to […]
